Foot and mouth disease virus vaccines

Vaccine

Volumn 27, Issue SUPPL. 4, 2009, Pages

  Rodriguez, Luis L ^a   Grubman, Marvin J ^a  

^a PLUM ISLAND ANIMAL DISEASE CENTER   (United States)

Author keywords

Disease; Foot and mouth; Vaccines; Virus

Indexed keywords

FOOT AND MOUTH DISEASE VACCINE; LIVE VACCINE; PEPTIDE VACCINE; RECOMBINANT PROTEIN;

ANIMAL PRODUCT; ANTIGEN PURIFICATION; FOOT AND MOUTH DISEASE; HUMAN; PRIORITY JOURNAL; REVIEW; SEROTYPE; SHELF LIFE; VACCINE PRODUCTION;

EID: 77954458311     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.08.039     Document Type: Review

References (75)

1. Sumption K, Rweyemamu M, Wint W. Incidence and distribution of foot-and mouth disease in Asia, Africa and South America, combining expert opinion, official disease information and livestock populations to assist risk assessment. Transboundary and Emerging Diseases 2008;55(1):5-13.
2. Gibbs P. The foot-and-mouth disease epidemic of 2001 in the UK: implications for the USA and the "war on terror". Journal of Veterinary Medical Education 2003;30(Summer 2):121-32.
3. Mort M, Convery I, Baxter J, Bailey C. Psychosocial effects of the 2001UKfoot and mouth disease epidemic in a rural population: qualitative diary based study. BMJ (Clinical Research Ed) 2005;331(7527):1234.
4. Mason PWaGMJ. Foot-and-mouth disease. In: BADTaS LR, editor. Vaccines. New York Academic Press; 2008. p. 361-77.
5. Rufael T, Catley A, Bogale A, Sahle M, Shiferaw Y. Foot and mouth disease in the Borana pastoral system, southern Ethiopia and implications for livelihoods and international trade. Tropical Animal Health and Production 2008;40(1):29-38.
6. Barasa M, Catley A, Machuchu D, Laqua H, Puot E, Tap Kot D, et al. Footand-mouth disease vaccination in South Sudan: benefit-cost analysis and livelihoods impact. Transboundary and Emerging Diseases 2008;55(8):339-51.
7. Perry BD, Rich KM. Poverty impacts of foot-and-mouth disease and the poverty reduction implications of its control. The Veterinary Record 2007;160(7):238-41.
8. Grubman MJ, Baxt B. Foot-and-mouth disease. Clinical Microbiology Reviews 2004;(2):465-93.
9. Pacheco JM, Arzt J, Rodriguez LL. Early events in the pathogenesis of foot-andmouth disease in cattle after controlled aerosol exposure. Veterinary Journal 2008;(October (16)).
10. Burrows R. Studies on the carrier state of cattle exposed to foot-and-mouth disease virus. The Journal of Hygiene 1966;64(1):81-90.
11. Golde WT, Pacheco JM, Duque H, Doel T, Penfold B, Ferman GS, et al. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: use in emergency outbreak response. Vaccine 2005;23(50):5775-82.
12. RweyemamuM, Roeder P, Mackay D, Sumption K, Brownlie J, Leforban Y, et al. Epidemiological patterns of foot-and-mouth disease worldwide. Transboundary and Emerging Diseases 2008;55(1):57-72.
13. Valarcher JF, Leforban Y, Rweyemamu M, Roeder PL, Gerbier G, Mackay DK, et al. Incursions of foot-and-mouth disease virus into Europe between, 1985 and 2006. Transboundary and Emerging Diseases 2008;55(1):14-34.
14. Lombard M, Pastoret PP, Moulin AM. A brief history of vaccines and vaccination. Revue Scientifique et Technique (International Office of Epizootics) 2007;26(1):29-48.
15. Waldmann O, Zimmermann T. Preparation of foot and mouth disease vaccine according to Waldmann and Kobe using calves as the antigen source. Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene 1 Abt Medizinisch-hygienische Bakteriologie, Virusforschung und Parasitologie 1955;163(4):239-44.
16. Capstick PB, Telling RC, Chapman WG, Stewart DL. Growth of a cloned strain of hamster kidney cells in suspended cultures and their susceptibility to the virus of foot-and-mouth disease. Nature 1962;195:1163-4.
17. Brown F, Hyslop NS, Crick J, Morrow AW. The use of acetylethyleneimine in the production of inactivated foot-and-mouth disease vaccines. The Journal of Hygiene 1963;61:337-44.
18. Bahnemann HG. The inactivation of foot and mouth disease virus by ethyleneimine and propyleneimine. Zbl Vet Med 1973;B20:356-60.
19. Michelsen E. Experiences on vaccination of pigs. Archiv fur experimentelle Veterinarmedizin 1961;15:317-21.
20. Doel TR. FMD vaccines. Virus Research 2003;91(1):81-99.
21. Laporte J. The structure of foot-and-mouth disease virus protein. The Journal of General Virology 1969;4(4):631-4.
22. Rowlands DJ, Sangar DV, Brown F. Relationship of the antigenic structure of foot-and-mouth disease virus to the process of infection. The Journal of General Virology 1971;13(1):85-93.
23. Laporte J, Grosclaude J, Wantyghem J, Bernard S, Rouze P. Neutralization of the infective power of the foot-and-mouth disease virus in cell culture by using serums from pigs immunized with a purified viral protein. Comptes rendus hebdomadaires des seances de l'Academie des sciences 1973;276(25):3399-401.
24. Bachrach HL, Moore DM, McKercher PD, Polatnick J. Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus. Journal of Immunology 1975;115(6):1636-41.
25. Kleid DG, Yansura D, Small B, Dowbenko D, Moore DM, Grubman MJ, et al. Cloned viral protein vaccine for foot-and-mouth disease: responses in cattle and swine. Science (New York, NY) 1981;214(4525):1125-9.
26. Acharya R, Fry E, Stuart D, Fox G, Rowlands D, Brown F. The threedimensional structure of foot-and-mouth disease virus at 2.9Å resolution. Nature 1989;337(6209):709-16.
27. Bittle JL, Houghten RA, Alexander H, Shinnick TM, Sutcliffe JG, Lerner RA, et al. Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 1982;298(5869):30-3.
28. DiMarchi R, Brooke G, Gale C, Cracknell V, Doel T, Mowat N. Protection of cattle against foot-and-mouth disease by a synthetic peptide. Science (New York, NY) 1986;232(4750):639-41.
29. Wigdorovitz A, Perez Filgueira DM, Robertson N, Carrillo C, Sadir AM, Morris TJ, et al. Protection of mice against challenge with foot and mouth disease virus (FMDV) by immunization with foliar extracts from plants infected with recombinant tobacco mosaic virus expressing theFMDVstructural protein VP1. Virology 1999;264(1):85-91.
30. Wigdorovitz A, Carrillo C, Dus Santos MJ, Trono K, Peralta A, Gomez MC, et al. Induction of a protective antibody response to foot and mouth disease virus in mice following oral or parenteral immunization with alfalfa transgenic plants expressing the viral structural protein VP1. Virology 1999;255(2):347-53.
31. Kit M, Kit S, Little SP, Di Marchi RD, Gale C. Bovine herpesvirus-1 (infectious bovine rhinotracheitis virus)-based viral vector which expresses foot-andmouth disease epitopes. Vaccine 1991;9(8):564-72.
32. Kitson JD, Burke KL, Pullen LA, Belsham GJ, Almond JW. Chimeric polioviruses that include sequences derived from two independent antigenic sites of footand-mouth disease virus (FMDV) induce neutralizing antibodies against FMDV in guinea pigs. Journal of Virology 1991;65(6):3068-75.
33. Wong HT, Cheng SC, Chan EW, Sheng ZT, Yan WY, Zheng ZX, et al. Plasmids encoding foot-and-mouth disease virus VP1 epitopes elicited immune responses in mice and swine and protected swine against viral infection. Virology 2000;278(1):27-35.
34. Taboga O, Tami C, Carrillo E, Nunez JI, Rodriguez A, Saiz JC, et al. A largescale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. Journal of Virology 1997;71(4):2606-14.
35. Rodriguez LL, Barrera J, Kramer E, Lubroth J, Brown F, Golde WT. A synthetic peptide containing the consensus sequence of the G-H loop region of foot-andmouth disease virus type-O VP1 and a promiscuous T-helper epitope induces peptide-specific antibodies but fails to protect cattle against viral challenge. Vaccine 2003;21(25-26):3751-6.
36. Domingo E, Mateu MG, Matnez MA, Dopazo J, Moya A, Sobrino F. Genetic variability and antigenic diversity of foot-and-mouth disease virus. In: KurstakFAM RGME, Regenmortel MHV, editors. Virus variability, epidemiology and control. New York: Plenum Publishing Corp.; 1990. p. 233-66.
37. Rowlands DJ, Sangar DV, Brown F. A comparative chemical and serological study of the full and empty particles of foot-and mouth disease virus. The Journal of General Virology 1975;26(3):227-38.
38. Rweyemamu MM, Terry G, Pay TW. Stability and immunogenicity of empty particles of foot-and-mouth disease virus. Archives of Virology 1979;59(1-2):69-79.
39. Roosien J, Belsham GJ, Ryan MD, King AM, Vlak JM. Synthesis of foot-andmouth disease virus capsid proteins in insect cells using baculovirus expression vectors. The Journal of General Virology 1990;71(August (Pt 8)):1703-11.
40. Lewis SA, Morgan DO, Grubman MJ. Expression, processing, and assembly of foot-and-mouth disease virus capsid structures in heterologous systems: induction of a neutralizing antibody response in guinea pigs. Journal of Virology 1991;65(12):6572-80.
41. Abrams CC, King AM, Belsham GJ. Assembly of foot-and-mouth disease virus empty capsids synthesized by a vaccinia virus expression system. The Journal of General Virology 1995;76(December (Pt 12)):3089-98.
42. Vakharia VN, Devaney MA, Moore DM, Dunn JJ, Grubman MJ. Proteolytic processing of foot-and-mouth disease virus polyproteins expressed in a cell-free system from clone-derived transcripts. Journal of Virology 1987;61(10):3199-207.
43. Grubman MJ, Lewis SA, Morgan DO. Protection of swine against foot-andmouth disease with viral capsid proteins expressed in heterologous systems. Vaccine 1993;11(8):825-9.
44. Saiz JC, Cairo J, Medina M, Zuidema D, Abrams C, Belsham GJ, et al. Unprocessed foot-and-mouth disease virus capsid precursor displays discontinuous epitopes involved in viral neutralization. Journal of Virology 1994;68(7):4557-64.
45. Chinsangaram J, Beard C, Mason PW, Zellner MK, Ward G, Grubman MJ. Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins. Journal of Virology 1998;72(5):4454-7.
46. Sanz-Parra A, Blasco R, Sobrino F, Ley V. Analysis of the B and T cell response in guinea pigs induced with recombinant vaccinia expressing foot-and-mouth disease virus structural proteins. Archives of Virology 1998;143(2):389-98.
47. Berinstein A, Tami C, Taboga O, Smitsaart E, Carrillo E. Protective immunity against foot-and-mouth disease virus induced by a recombinant vaccinia virus. Vaccine 2000;18(21):2231-8.
48. Sanz-Parra A, Vazquez B, Sobrino F, Cox SJ, Ley V, Salt JS. Evidence of partial protection against foot-and-mouth disease in cattle immunized with a recombinant adenovirus vector expressing the precursor polypeptide (P1)of foot-and-mouth disease virus capsid proteins. The Journal of General Virology 1999;80(March (Pt 3)):671-9.
49. Mayr GA, Chinsangaram J, Grubman MJ. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate. Virology 1999;263(2):496-506.
50. Mayr GA, O'Donnell V, Chinsangaram J, Mason PW, Grubman MJ. Immune responses and protection against foot-and-mouth disease virus (FMDV) hallenge in swine vaccinated with adenovirus-FMDV constructs. Vaccine 2001;19(February (15-16)):2152-62.
51. Moraes MP, Mayr GA, Mason PW, Grubman MJ. Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24. Vaccine 2002;20(February (11-12)):1631-9.
52. Pacheco JM, Brum MC, Moraes MP, Golde WT, Grubman MJ. Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine. Virology 2005;337(2):205-9.
53. Ma M, Jin N, Shen G, Zhu G, Liu HJ, Zheng M, et al. Immune responses of swine inoculated with a recombinant fowlpox virus co-expressing P12A and 3C of FMDV and swine IL-18. Veterinary Immunology and Immunopathology 2008;121(January (1-2)):1-7.
54. Li Z, Yi Y, Yin X, Zhang Z, Liu J. Expression of foot-and-mouth disease virus capsid proteins in silkworm-baculovirus expression system and its utilization as a subunit vaccine. PloS One 2008;3(5):e2273.
55. Mingxiao M, Ningyi J, Juan LH, Min Z, Guoshun S, Guangze Z, et al. Immunogenicity of plasmids encoding P12A and 3C of FMDV and swine IL-18. Antiviral Research 2007;76(1):59-67.
56. Li X, Liu R, Tang H, Jin M, Chen H, Qian P. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus. Vaccine 2008;26(22):2714-22.
57. Mowat GN, Brooksby JB, Pay TW. Use of BHK 21 cells in the preparation of mouse attenuated live foot-and-mouth disease vaccines for the immunization of cattle. Nature 1962;196:655-6.
58. Martin WB, Edwards LT. A field trial in south africa of an attenuated vaccine against foot-and-mouth disease. Research in Veterinary Science 1965;6:196-201.
59. Zhidkov SA, Sergeev VA. A study of the properties of attenuated cold variant of type O foot-and-mouth disease virus. Veterinariia 1969;10:29-31.
60. Mowat GN, Barr DA, Bennett JH. The development of an attenuated foot-andmouth disease virus vaccine by modification and cloning in tissue cultures of BHK21 cells. Archiv fur die gesamte Virusforschung 1969;26(4):341-54.
61. Rieder E, Bunch T, Brown F, Mason PW. Genetically engineered foot-and-mouth disease viruses with poly (C)tracts of two nucleotides are virulent in mice. Journal of Virology 1993;67(9):5139-45.
62. Rieder E, Baxt B, Lubroth J, Mason PW. Vaccines prepared from chimeras of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies and protective immunity to multiple serotypes of FMDV. Journal of Virology 1994;68(11):7092-8.
63. Strebel K, Beck E. A second protease of foot-and-mouth disease virus. Journal of Virology 1986;58(3):893-9.
64. Devaney MA, Vakharia VN, Lloyd RE, Ehrenfeld E, Grubman MJ. Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex. Journal of Virology 1988;62(11): 4407-9.
65. de Los Santos T, de Avila Botton S, Weiblen R, Grubman MJ. The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response. Journal of Virology 2006;80(4):1906-14.
66. de Los Santos T, Diaz-San Segundo F, Grubman MJ. Degradation of nuclear factor kappa B during foot-and-mouth disease virus infection. Journal of Virology 2007;81(23):12803-15.
67. Brown CC, Piccone ME, Mason PW, McKenna TS, Grubman MJ. Pathogenesis of wild-type and leaderless foot-and-mouth disease virus in cattle. Journal of Virology 1996;70(8):5638-41.
68. Mason PW, Piccone ME, McKenna TS, Chinsangaram J, Grubman MJ. Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate. Virology 1997;227(1):96-102.
69. Chinsangaram J, Mason PW, Grubman MJ. Protection of swine by live and inactivated vaccines prepared from a leader proteinase-deficient serotype A12 foot-and-mouth disease virus. Vaccine 1998;16(16):1516-22.
70. de Avila Botton S, Brum MC, Bautista E, Koster M, Weiblen R, Golde WT, et al. Immunopotentiation of a foot-and-mouth disease virus subunit vaccine by interferon alpha. Vaccine 2006;24(17):3446-56.
71. Pena L, Moraes MP, Koster M, Burrage T, Pacheco JM, Segundo FD, et al. Delivery of a foot-and-mouth disease virus empty capsid subunit antigen with nonstructural protein 2B improves protection of swine. Vaccine 2008;26(45):5689-99.
72. Rieder E, Henry T, Duque H, Baxt B. Analysis of a foot-and-mouth disease virus type A24 isolate containing an SGD receptor recognition site in vitro and its pathogenesis in cattle. Journal of Virology 2005;79(20):12989-98.
73. Sa-Carvalho D, Rieder E, Baxt B, Rodarte R, Tanuri A, Mason PW. Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle. Journal of Virology 1997;71(7):5115-23.
74. Mateo R, Luna E, Rincon V, Mateu MG. Engineering viable foot-and-mouth disease viruses with increased thermostability as a step in the development of improved vaccines. Journal of Virology 2008;82(24):12232-40.
75. McKenna TS, Lubroth J, Rieder E, Baxt B, Mason PW. Receptor binding sitedeleted foot-and-mouth disease (FMD) virus protects cattle from FMD. Journal of Virology 1995;69(9):5787-90.